Achieving targets for bone and mineral metabolism: The impact of cinacalcet HCl in clinical practice

Hemodialysis International

Volumn 10, Issue SUPPL. 2, 2006, Pages

  Spiegel, David M ^a   Casey, Lynn ^b   Bell, Susan ^b   Parker, Michelle ^b   Chonchol, Michel ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Renal Care Group   (United States)

Author keywords

Cinacalcet HCl; K DOQI targets; Mineral metabolism

Indexed keywords

CALCIUM; CINACALCET; PARATHYROID HORMONE; PARICALCITOL; PHOSPHORUS;

ADULT; ALGORITHM; BONE METABOLISM; CALCIUM BLOOD LEVEL; CLINICAL OBSERVATION; CLINICAL PRACTICE; CONFERENCE PAPER; CONTROLLED STUDY; DIALYSIS; DRUG EFFECT; DRUG SUBSTITUTION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MINERAL METABOLISM; PARATHYROID HORMONE BLOOD LEVEL; PATIENT COMPLIANCE; SECONDARY HYPERPARATHYROIDISM; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE AND BONES; CALCIUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NAPHTHALENES; PARATHYROID HORMONE; PHOSPHORUS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33749345013     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2006.00116.x     Document Type: Conference Paper

References (2)

1. Block GA, Martin KJ, de Francisco AL, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004; 350: 1516-1525.
2. Moe SM, Chertow GM, Coburn JW, et al. Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int. 2005; 67: 760-771.